Cargando…

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection

Dornase alfa, the recombinant form of the human DNase I enzyme, breaks down neutrophil extracellular traps (NET) that include a vast amount of DNA fragments, histones, microbicidal proteins and oxidant enzymes released from necrotic neutrophils in the highly viscous mucus of cystic fibrosis patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okur, H.K., Yalcin, K., Tastan, C., Demir, S., Yurtsever, B., Karakus, G.S., Kancagi, D.D., Abanuz, S., Seyis, U., Zengin, R., Hemsinlioglu, C., Kara, M., Yildiz, M.E., Deliceo, E., Birgen, N., Pelit, N.B., Cuhadaroglu, C., Kocagoz, A.S., Ovali, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	First Clinical Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476504/ https://www.ncbi.nlm.nih.gov/pubmed/32922804 http://dx.doi.org/10.1016/j.nmni.2020.100756

Ejemplares similares

In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
por: Hemşinlioğlu, Cansu, et al.
Publicado: (2023)

SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
por: TAŞTAN, Cihan, et al.
Publicado: (2020)

Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
por: Erdoğan, Ebru, et al.
Publicado: (2022)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
por: Sir Karakus, Gozde, et al.
Publicado: (2021)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2020)

Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
por: Taştan, Cihan, et al.
Publicado: (2020)

Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice
por: Turan, Raife Dilek, et al.
Publicado: (2021)

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
por: Earhart, A.P., et al.
Publicado: (2020)

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome
por: Toma, Andrew, et al.
Publicado: (2021)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19
por: Holliday, Zachary M., et al.
Publicado: (2021)

Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure
por: Hatirnaz Ng, Ozden, et al.
Publicado: (2021)

Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
por: den Hollander, Bibiche, et al.
Publicado: (2022)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: clinical results of 6 months follow-up
por: Özkan, Berna, et al.
Publicado: (2023)

The Therapeutic Significance of Mesenchymal Stem Cells in COVID-19 Acute Pulmonary Respiratory Disease
por: Kançağı, Derya Dilek, et al.
Publicado: (2022)

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study
por: Jiang, Chuan, et al.
Publicado: (2020)

microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model
por: Arisan, Elif Damla, et al.
Publicado: (2022)

The effects of thymoquinone on pancreatic cancer and immune cells
por: Alandağ, Celal, et al.
Publicado: (2022)

P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Yalcin, Koray, et al.
Publicado: (2023)

Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
por: Claudius, Casper, et al.
Publicado: (2015)

Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients
por: Pottecher, Julien, et al.
Publicado: (2020)

USE OF ALTEPLASE AND DORNASE FOR LYSIS OF COVID-19-RELATED LOCULATED PLEURAL EFFUSION
por: STAIANO, PETER P, et al.
Publicado: (2022)

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial
por: Desilles, J. P., et al.
Publicado: (2020)

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer
por: Toader, Dorin, et al.
Publicado: (2023)

Preparation of Cell-Loaded Microbeads as Stable and Injectable Delivery Platforms for Tissue Engineering
por: Karaca, Mehmet Ali, et al.
Publicado: (2023)

Welcoming patients into our eye service
por: Pons, Jonathan
Publicado: (2012)

Epidemiological and genetic considerations in retinoblastoma
por: Fabian, Ido Didi, et al.
Publicado: (2018)

TNM8: The updated TNM classification for retinoblastoma
Publicado: (2018)

Standard reporting of high-risk histopathology features in retinoblastoma
por: Thaung, Caroline, et al.
Publicado: (2018)

First person – Amy Findlay
Publicado: (2018)

First person – Jennifer Hewitt
Publicado: (2018)

First person – Bao-Luen Chang
Publicado: (2018)

First person – Matthew T. Pereira
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8ekhgd687k8sjj2dml8ojp43io